TransScript® All-in-One First-Strand cDNA Synthesis SuperMix for PCR-北京意昂3(TransGen Biotech)_官方主页




意昂3_意昂3平台_意昂3代理-「官方直营招商注册入口」

TransScript® All-in-One First-Strand cDNA Synthesis SuperMix for PCR

TransScript All-in-One 单链合成试剂盒 for PCR

目录号规格单价
AT321-0150 rxns×20 µl体系1260
说明书
质检报告
立即下单
加入购物车

产品详情介绍

本产品含有反转录反应所需的全部试剂(TransScript® RT, RNase Inhibitor, Anchored Oligo(dT)18 Primer,Random Primer(N9), dNTPs, Buffer),浓度为5×。反应时,只需加入模板RNA和水即可高效合成第一链cDNA。操作简便,降低操作过程中的污染机率。cDNA 用于常规PCR,不推荐用于qPCR。

产品组成

1637723339364825.png

使用前请将各组分点甩离心

References

1 Deng P, Wang Z, Chen J, et al. RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer[J]. The Journal of Clinical Investigation, 2022.(IF 19.45)

2 Wu Z, Liu D, Pan D, et al. Structure and engineering of miniature Acidibacillus sulfuroxidans Cas12f1[J]. Nature Catalysis, 2023.(IF 37.80)

3 Liu S, Zou Q, Chen J P, et al. Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer[J]. The Journal of Clinical Investigation, 2021.(IF 19.45)

4 Wang D, Zhang Y, Xu X, et al. YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3[J]. Nature communications, 2021.(IF 12.12)

5 Liu L, Liu S, Deng P, et al. Targeting the IRAK1–S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma[J]. Cancer Research, 2021.(IF 12.70)


FAQ
产品指南

质检报告

登录

captcha

注册

*收货地址:
captcha

客服

微信

友情链接: